Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies

Ferrán Catalá-López; Marta Suárez‐Pinilla; Paula Suárez‐Pinilla; José M Valderas; Manuel Gómez-Beneyto; Salvador Martı́nez; Vicent Balanzá‐Martínez; Joan Climent; Alfonso Valencia; John J. McGrath; Benedicto Crespo‐Facorro; José Sánchez‐Moreno; Eduard Vieta; Rafael Tabarés‐Seisdedos

doi:10.1159/000356498

Shared by

Eduard Vieta

Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies

Article 2014 en

Authors

FC
Ferrán Catalá-López
MS
Marta Suárez‐Pinilla
PS
Paula Suárez‐Pinilla

Abstract

1 min read

Increased and decreased co-occurrence of cancer in patients with CNS disorders represents an opportunity to discover biological and non-biological connections between these complex disorders.

Discussion(0)

No comments yet. Be the first to comment.

Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies

Abstract

Discussion(0)

Related publications

Global pattern of brain and central nervous system cancer incidence

Incidence and risk factors for central nervous system (CNS) metastasis (met) in patients (pts) with stage III melanoma treated with adjuvant (ADJ) anti-PD1 immunotherapy (IMT).

Defining Central Nervous System Involvement in Patients with Acquired Demyelinating Peripheral Neuropathies (S25.002)

Identification of biomarkers for predicting central nervous system involvement in patients with diffuse large B‐cell lymphoma

Low-Level Laser Therapy in Stroke and Central Nervous System

Related publications

Article2016
Global pattern of brain and central nervous system cancer incidence
Article2016

Article2024
Incidence and risk factors for central nervous system (CNS) metastasis (met) in patients (pts) with stage III melanoma treated with adjuvant (ADJ) anti-PD1 immunotherapy (IMT).
Article2024

Article2015
Defining Central Nervous System Involvement in Patients with Acquired Demyelinating Peripheral Neuropathies (S25.002)
Article2015

Article2023
Identification of biomarkers for predicting central nervous system involvement in patients with diffuse large B‐cell lymphoma
Article2023

Chapter in a book2010
Low-Level Laser Therapy in Stroke and Central Nervous System
Chapter in a book2010